Long-Acting Lipoglycopeptides for Gram-Positive Bacteremia at the End of Life to Facilitate Hospice Care: A Report of 3 Cases | Zendy

Rupak Datta | Zendy; Dayna McManus | Zendy; Jeffrey Topal | Zendy; Manisha JuthaniMehta | Zendy

Open Access

Long-Acting Lipoglycopeptides for Gram-Positive Bacteremia at the End of Life to Facilitate Hospice Care: A Report of 3 Cases

Author(s) -

Rupak Datta,

Dayna McManus,

Jeffrey Topal,

Manisha JuthaniMehta

Publication year - 2018

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofx277

Subject(s) - bacteremia , medicine , hospice care , staphylococcus aureus , intensive care medicine , gram positive cocci , end of life care , microbiology and biotechnology , palliative care , nursing , antibiotics , bacteria , biology , genetics

Administering and monitoring intravenous antimicrobials may cause discomfort in patients at the end of life and delay transition to hospice. We describe 3 patients with terminal cancer with methicillin-resistant , and bacteremia who were managed with the long-acting lipoglycopeptide oritavancin to facilitate discharge to hospice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research